PE exits in tech services stretch thin as valuation gaps widenAnalysts said the valuations are getting more realistic with some estimating markdowns of up to 30-40% in 2026 over 2025, mirroring the mar...
16 Sep, 2026, 07.33 PM IST
NSE IPO GMP at 12% as stock exchange announces price band, key dates. 10 things to knowNSE’s IPO is set to raise around Rs 22,662 crore, with the latest grey market premium at 11–12% after the exchange fixed its price band. Th...
15 Sep, 2026, 12.55 PM IST
NSE IPO set to open for public on September 17; price band at Rs 1,700-1,785The National Stock Exchange of India's IPO opens September 17, closing September 21. Its price band is set between ₹1,700 and ₹1,785 per sh...
12 Sep, 2026, 08.28 AM IST
Marengo Asia Hospitals raises Rs 400 crore from LeapFrog InvestmentsMarengo Asia Hospitals has secured Rs. 400 crore funding from LeapFrog Investments. This capital will fuel expansion into tier one and two ...
11 Sep, 2026, 11.21 AM IST
NSE IPO: 8 selling shareholders trim stake sale as offer size cut by over 15%, RHP showsNSE has reduced its IPO offer for sale to 12.64 crore shares from 14.89 crore shares, with eight shareholders cutting their proposed stake ...
11 Sep, 2026, 09.24 AM IST
NSE IPO price band for Rs 22,561-crore offer announced! Check key dates, other important detailsRetail investors have been allocated 35% of the issue, while 50% has been reserved for eligible institutional bidders (QIBs). The remaining...
11 Sep, 2026, 08.21 AM IST
Symbiotec Pharmalab shares list at 1% discount to IPO priceThe Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstan...
01 Sep, 2026, 10.08 AM IST
Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
27 Aug, 2026, 07.17 PM IST
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
26 Aug, 2026, 06.21 PM IST
InCred hires Avendus wealth experts to launch new platform for ultra-high-net-worth individualsInCred recently welcomed three senior professionals from the competition, Avendus, to establish a dedicated platform aimed at ultra-high-ne...
25 Aug, 2026, 01.16 PM IST
Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
24 Aug, 2026, 11.49 AM IST
Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
21 Aug, 2026, 09.21 PM IST
Private credit deals drop 61 pc to USD 3.5 bn in H1 2026: ReportPrivate credit deployments saw a sharp 61 percent drop in early 2026. This decline occurred amid a volatile macro economic environment and ...
20 Aug, 2026, 07.06 PM IST
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
19 Aug, 2026, 09.04 AM IST
Zetwerk files updated IPO papers with Sebi; plans to raise Rs 2,600-cr via fresh issueZetwerk Manufacturing Business Ltd has updated its IPO papers to initiate a substantial Rs 2,600 crore offering. The funds raised are earma...
14 Aug, 2026, 10.56 AM IST
Leap India raises Rs 743.6 crore from 32 anchor investors ahead of IPO launchThe anchor allocation witnessed participation from some of the world’s most prominent institutional investors, including the Monetary Autho...
07 Aug, 2026, 07.46 AM IST
REIT mutual funds vs REITs: Why the fund route may be the smarter betDespite their benefits, REITs have not found widespread acceptance. Tax treatment is a major hurdle. When investing directly in REITs, inve...
03 Aug, 2026, 11.40 AM IST